GE Healthcare Technologies (GEHC) said Wednesday it has received the US Food and Drug Administration's 510(k) clearance for its SIGNA MAGNUS, a head-only magnetic resonance imaging scanner.
The company said the system helps detect neurological, oncological and psychiatric conditions.
The device will be available for new production and as an upgrade for existing SIGNA Premier systems, allowing facilities to access advanced technology without requiring new systems or extra power and cooling.
Price: 85.63, Change: +0.24, Percent Change: +0.28
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments